Print

IAVI 008

To evaluate safety, tolerability, and immune response of MVA.HIVA

Trial Details:

I Completed
Keyna AIDS Vaccine Initiative (KAVI, International AIDS Vaccine Initiative (IAVI) January 01, 2003
MVA.HIVA Gag A
MVA.HIVA Viral Vector - Pox
Kenya 10
http://www.iavi.org